Amaryllidaceae alkaloids inhibit nuclear-to-cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian influenza virus H5N1

Influenza and other Respiratory Viruses

Volumn 7, Issue 6, 2013, Pages 922-931

  He, Jun ^a,b,c   Qi, Wen Bao ^a,b   Wang, Lei ^c   Tian, Jin ^a,b   Jiao, Pei Rong ^a,b   Liu, Guo Qian ^a,b   Ye, Wen Cai ^c   Liao, Ming ^a,b  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

Amaryllidaceae alkaloid; H5N1 influenza A virus; VRNP export

Indexed keywords

11 HYDROXY VITTATINE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 9 O DEMETHYLHOMOLYCORINE; AMARYLLIDACEAE ALKALOID; DEMETHYMARITIDINE; DIHYDROLYCORINE; GALANTAMINE; GALANTHINE; HAEMANTHAMINE; HIPPEASTRINE; LYCORAMINE; LYCORENINE; LYCORINE; NUCLEOCAPSID PROTEIN; O DEMETHYLYCORAMINE; O METHYLLYCORENINE; OUTER MEMBRANE PROTEIN; RIBONUCLEOPROTEIN; SIALIDASE; TRISPHAERIDINE; UNCLASSIFIED DRUG; UNGEREMINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; AVIAN INFLUENZA VIRUS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; HEMAGGLUTINATION INHIBITION; IMMUNOFLUORESCENCE; IN VITRO STUDY; INFLUENZA VIRUS A H5N1; LYCORIS; LYCORIS RADIATA; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT BULB; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION;

AMARYLLIDACEAE ALKALOID; H5N1 INFLUENZA A VIRUS; VRNP EXPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; AMARYLLIDACEAE ALKALOIDS; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CHICKENS; DOGS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; LYCORIS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; RIBONUCLEOPROTEINS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRUS REPLICATION;

EID: 84887137193     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12035     Document Type: Article

References (47)

1. Palese P. Influenza: old and new threats. Nat Med 2004; 10(Suppl 12):S82-S87.
2. Palese P, Shaw ML. "Orthomyxoviridae: the viruses and their replication". In: Knipe DM, Howley PM, Griffin DE et al. (eds) Fields Virol 2007:1647-1689. Philadelphia: Wolters Kluwer; Lippincott Williams & Wilkins.
3. Palese P, Wang TT. H5N1 influenza viruses: facts, not fear. Proc Natl Acad Sci U S A. 2012 Feb 14; 109:2211-3.
4. Wainright PO, Perdue ML, Brugh M, Beard CW. Amantadine resistance among hemagglutinin subtype 5 strains of avian influenza virus. Avian Dis 1991; 35:31-39.
5. Bahlky H. Avian influenza: the tip of the iceberg. Ann Thorac Med 2009; 3:154-157.
6. Suzuki Y. The highly pathogenic avian influenza H5N1-initial molecular signals for the next influenza pandemic. Chang Gung Med J 2009; 32:258-263.
7. Cannell JJ, Zasloff M, Giovannucci E. On the epidemiology of influenza. Virology J 2008; 5:29.
8. Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold?Clin Infec Dis 2009; 48:S3-S13.
9. Jefferson T, Di Pietrantonj C, Debalini MG, Rivetti A, Demicheli V. Inactivated influenza vaccines: methods, policies, and politics. J Clin Epidemiol 2009; 62:677-686.
10. Lackenby A, Thompson CI, Democratis J. The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infec Dis 2008; 21:626-638.
11. Linhares RE, Wigg MD, Lagrota MH, Nozawa CM. The in vitro antiviral activity of isoprinosine on simian rotavirus (SA-11). Braz J Med Biol Res 1989; 22:1095-1103.
12. Cheng PKC, Leung TWC, Ho ECM et al. Oseltamivir- and amantadine-resistant influenza viruses A (H1N1). Emerg Infec Dis 2009; 15:966-968.
13. Kitching A, Roche A, Balasegaram S, Heathcock R, Maguire H. Oseltamivir adherence and side effects among children in three London schools affected by influenza A (H1N1) v, May 2009 an internet-based cross-sectional survey. Eurosurveillance 2009; 14:1-4.
14. Dutkowski R. Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. J Antimicrob Chemother 2010; 65(Suppl 2):ii11-ii24.
15. Kretzing S, Abraham G. Dose-dependent emetic effects of the Amaryllidaceous alkaloid lycorine in beagle dogs. Toxicon 2011; 57:117-124.
16. Dewick PM. The biosynthesis of C5-C25 terpenoid compounds. Nat Prod Rep 2002; 19:181-222.
17. Jin Z. Amaryllidaceae and Sceletium alkaloids. Nat Prod Rep 2003; 20:606-614.
18. Jin Z. Amaryllidaceous and Sceletium alkaloids. Nat Prod Rep 2007; 24:886-905.
19. Zupkó I, Réthy B, Hohmann J, Molnár J, Ocsovszki I, Falkay G. Antitumor activity of alkaloids derived from Amaryllidaceae species. In Vivo 2009; 23:41-48.
20. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1996; 19:1518-1520.
21. DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978; 235:E97-E102.
22. Li C, Hatta M, Watanabe S, Neumann G, Kawaoka Y. Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses. J Virol 2008; 82:11880-11888.
23. Leung BW, Chen H, Brownlee GG. Correlation between polymerase activity and pathogenicity in two duck H5N1 influenza viruses suggests that the polymerase contributes to pathogenicity. Virology 2010; 401:96-106.
24. Liu SW, Li RM, Zhang R et al. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry. Eur J Pharmacol 2011; 660:460-467.
25. Zheng B, Mittal SK, Graham FL, Prevec L. The E1 sequence of bovine adenovirus type 3 and complementation of human adenovirus type 5 E1A function in bovine cells. Virus Res 1994; 31:163-186.
26. Kwon H-J, Kim H-H, Yoon SY. In Vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination. Virology J 2010; 7:307.
27. Shin Y-K, Liu Q, Tikoo S-K, Babiuk L-A, Zhou Y. Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. J Gen Virol 2007; 88:942-950.
28. Wu M-S, Yen HR, Chang CW, et al. Mechanism of action of the suppression of influenza virus replication by Ko-Ken Tang through inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway and viral RNP nuclear export. J Ethnopharmacol 2011; 134:614-623.
29. Li C, Liu VW, Chan DW, Yao KM, Ngan HY. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells. Int J Gynecol Cancer 2012; 22:15-22.
30. Lamb J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 2007; 7:54-60.
31. 13C NMR analysis if lycorine and α-dihydrolycorine. Phytochemistry 1983; 22:581-584.
32. Viladomat F, Giovanna R, Bastida J. Alkaloids from Brunsvigia orientalis. Phytochemistry 1996; 43:1379-1384.
33. 13C nuclear magnetic resonance spectra of Amaryllidaceae alkaloids. Magn Reson Chem 1985; 23:804-808.
34. Masaru KiHRA, Konishi K, Lai XU, Shigeru Kobayashi. Alkaloidal constituents of flowers of lycoris radiate HERB (Amaryllidaceae). Chem Pharm Bull 1991; 39:1848-1853.
35. Evidente A. Identification of 1 1-Hydroxwittatine in Sternbergialutea lutea. J Nat Prod 1986; 49:168-169.
36. Evidente A, Andolfi A, Shawky E. (-)-Amarbellisine, a lycorine-type alkaloid from Amaryllis belladonna L. growing in Egypt. Phytochemistry 2004; 65:2113-2118.
37. Latvala A. Alkaloids of Galanthus elwesii. Phytochemistry 1995; 39:1229-1240.
38. Wagner J, Huong L. Alkaloids from Hippeastrum Equestre Herb-5. Circular Dichroism Studies. Tetrahedron 1996; 52:6591-6600.
39. Li SY, Chen C, Tan XH. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005; 67:18-23.
40. Liu JG, Zhang LF. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virology J 2011; 8:483.
41. Szlávik L, Gyuris A, Minárovits J, Forgo P, Molnár J, Hohmann J. Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids. Planta Med 2004; 70:871-873.
42. CDC. Transmission of influenza A viruses between animals and people, the virus and its spread. 2005; October 17.
43. Dickneite; Gerhard (Marburg-Cappel, DE) Schorlemmer; Hans-UAAich (Weimar, DE) Sedlacek; Hans-Harald (Marburg, DE). Use of Lycorine as an immunosuppressor. 4699912 October 13, 1987.
44. Yui S, Mikami M, Kitahara M, Yamazaki M. The inhibitory effect of lycorine on tumor cell apoptosis induced by polymorphonuclear leukocyte-derived calprotectin. Immunopharmacology 1998; 40:151-162.
45. Ancuceanu RV, Istudor V. Pharmacologically active natural compounds for lung cancer. Altern Med Rev 2004; 9:402-419.
46. Van Goietsenoven G, Andolfi A. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells. J Nat Prod 2010; 73:1223-1227.
47. Evidente A, Kireev AS, Jenkins AR, Romero AE, Kornienko A. Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Med 2009; 75:501-507.